Achillion Pharmaceuticals, Inc. (ACHN) saw a big move in the last trading session, as the company’s shares fell by nearly 16% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for ACHN, as the stock is now up nearly 3% in the past one-month time frame.
The biopharmaceutical company has not seen any estimate revision over the past month, and the current year earnings consensus hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, especially on earnings estimates following the recent slump.
ACHN currently holds a Zacks Rank #3 (Hold).
Investors interested in the Medical – Biomed/Gene industry may consider better-ranked stocks like AMAG Pharmaceuticals, Inc. (AMAG), Heska Corporation (HSKA) and Agenus Inc. (AGEN), each carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment